Commoditization happens when supply of providers exceeds demand for service. Fees compress. Patient loyalty disappears. Practitioners become substitutable. In India, this process is happening in waves: General practice was commoditized 10 years ago (fees dropped from ₹300-500 to ₹100-200 as practitioner density increased). Psychiatry is being commoditized now (fees are dropping as practitioner supply increased 3x in 5 years). Dermatology is next (supply increasing 40% faster than demand). Radiology is partially commoditized already (AI reading systems create price competition). The data shows: When practitioner-to-population ratio exceeds 1:5,000, commoditization begins. When it exceeds 1:3,000, commoditization is entrenched (fees decline 30-50%, patient switching increases, quality competition becomes price competition). Knowing which specialties are commoditizing helps you decide: specialization urgently, or career transition before it's too late.
Understanding Commoditization: The Economic Model
Commoditization follows a predictable pattern:
Stage 1: Specialty emergence (practitioner-to-population 1:50,000)
- Few practitioners
- High fee-setting power (₹2000-5000 per patient)
- Patient loyalty is high (few alternatives)
- Income is very high (₹100+ lakh for top practitioners)
- Example: Interventional radiology 15 years ago
Stage 2: Growing supply (practitioner-to-population 1:20,000)
- More practitioners entering specialty
- Fee stability (fees stay at ₹1500-3000)
- Patient choices increase
- Income remains high (₹60-100 lakh)
- Example: Cardiology 10 years ago
Stage 3: Market saturation (practitioner-to-population 1:5,000)
- Supply catching up with demand
- Fees begin declining (₹1000-2000)
- Patient switching increases (alternatives available)
- Income declining (₹40-60 lakh, pressure on margins)
- Quality becomes differentiator
- Example: Psychiatry current state
Stage 4: Commoditization (practitioner-to-population <1:3,000)
- Oversupply of practitioners
- Fees compressed dramatically (₹300-800)
- Patients choose based on price/location, not expertise
- Income severely reduced (₹20-30 lakh)
- Quality competition irrelevant (patient cannot assess quality before choosing)
- Example: General practice, basic dermatology
Which Specialties Are in Each Stage Currently?
Already Commoditized (Stage 4):
| Specialty | Practitioner Ratio | Current Fees | Current Income | Stage Duration |
|---|---|---|---|---|
| General practice | 1:2,500 | ₹100-250 | ₹15-30 lakh | 10+ years (stable commoditized state) |
| Basic pediatrics | 1:3,500 | ₹150-350 | ₹20-40 lakh | 8-10 years |
| General dentistry | 1:2,000 | ₹300-800 | ₹20-35 lakh | 12+ years (severely commoditized) |
| Homeopathy (basic) | 1:1,500 | ₹50-150 | ₹10-20 lakh | 15+ years |
| Dermatology (general) | 1:6,000 (approaching saturation) | ₹600-1200 | ₹30-50 lakh | 3-5 years into commoditization |
Currently Commoditizing (Stage 3):
| Specialty | Practitioner Ratio | Current Fees | Current Income | Trend |
|---|---|---|---|---|
| Psychiatry | 1:4,000 (and increasing) | ₹800-2000 | ₹30-50 lakh | Rapidly commoditizing (10-year plan exists to add 50,000 psychiatrists) |
| General orthopedics | 1:5,500 | ₹800-1500 | ₹40-60 lakh | Slowly commoditizing (joint replacement becoming more competitive) |
| General surgery | 1:6,000 | ₹1000-2000 | ₹50-80 lakh | Early commoditization (simple procedures becoming price-competitive) |
| Anesthesia | 1:7,000 | ₹2000-5000 (procedure-dependent) | ₹50-80 lakh | Early commoditization (supply increasing faster than demand) |
| ENT | 1:6,500 | ₹1000-2000 | ₹40-70 lakh | Moderate commoditization (practitioner supply increasing) |
Growing, No Commoditization Yet (Stage 2):
| Specialty | Practitioner Ratio | Current Fees | Current Income | Stability |
|---|---|---|---|---|
| Cardiology interventional | 1:15,000 | ₹5000-20,000 | ₹100-200+ lakh | Very high (specialty niche, few practitioners) |
| Liver transplantation | 1:30,000 (ultra-rare) | ₹20,000-50,000+ | ₹150-300+ lakh | Very high (scarcity) |
| Pediatric cardiology | 1:100,000 | ₹3000-8000 | ₹80-150 lakh | Very high (ultra-niche) |
| Reproductive medicine (IVF) | 1:20,000 | ₹5000-30,000 | ₹80-200 lakh | High (demand exceeds supply nationally) |
| Nephrology interventional | 1:20,000 | ₹3000-15,000 | ₹60-120 lakh | High (procedures in demand, specialists scarce) |
| Pain management (interventional) | 1:25,000 | ₹5000-15,000 | ₹80-150 lakh | Very high (new specialty, huge demand) |
| Neuro-oncology | 1:50,000 | ₹5000-20,000 | ₹100-180 lakh | Very high (ultra-specialized, few practitioners) |
Emerging, Currently Advantaged (Stage 1):
| Specialty | Practitioner Ratio | Current Fees | Current Income | Outlook |
|---|---|---|---|---|
| Robotic surgery | 1:100,000+ | ₹20,000-50,000+ | ₹150-300+ lakh | Very high (cutting-edge, scarcity value) |
| Minimal-access tumor surgery | 1:40,000 | ₹10,000-30,000 | ₹120-200 lakh | Very high (complex, few trained) |
| Stem cell medicine | 1:1,000,000+ (globally) | ₹50,000-200,000 | ₹150-300+ lakh | Extremely high (frontier, regulation evolving) |
| Minimal-access gynecology (advanced) | 1:50,000 | ₹5000-15,000 | ₹80-150 lakh | High (new modality, growing demand) |
| Interventional neuro | 1:100,000 | ₹10,000-40,000 | ₹150-250+ lakh | Very high (scarcity, high complexity) |
The Commoditization Trajectory: Timelines and Inflection Points
Recent examples show the commoditization curve:
Psychiatry (Current Case Study):
- 2010: 1:50,000 practitioners, ₹3000-5000 fees, ₹100+ lakh income (rare specialty)
- 2015: 1:15,000 practitioners, ₹2000-3000 fees, ₹70-100 lakh income (supply increasing)
- 2020: 1:6,000 practitioners, ₹1000-2000 fees, ₹40-60 lakh income (saturating)
- 2025: 1:4,000 practitioners, ₹800-1500 fees, ₹30-50 lakh income (commoditizing)
- Trajectory: 15 years from ₹100+ lakh income to ₹30-50 lakh income (70% reduction)
Government's NMHP (National Mental Health Program) explicitly plans to add 50,000 psychiatrists by 2030. This planned supply explosion will accelerate commoditization.
Dermatology (5-Year Look-Ahead):
- 2020: 1:10,000 practitioners, ₹1000-1500 fees, ₹50-70 lakh income
- 2025: 1:6,000 practitioners, ₹600-1200 fees, ₹30-50 lakh income (commoditizing starting)
- 2030: 1:4,000 practitioners, ₹400-800 fees, ₹20-35 lakh income (fully commoditized expected)
- Trajectory: 10 years from ₹50-70 lakh income to ₹20-35 lakh income (60% reduction expected)
Dermatology is commoditizing because:
- 1It's popular among medical students (high cutoff marks to get dermatology seat)
- 2Practitioner supply increasing faster than demand
- 3Basic dermatology (acne, eczema) has low barriers to entry (simple cases, easy diagnosis)
- 4Online competition from international dermatologists (telehealth from USA dermatologists offering ₹50-200 consultations)
The Data: Practitioner Density Predicts Commoditization
The correlation is strong: As practitioner-to-population ratio decreases (more practitioners per population), fees decline:
| Practitioner Ratio | Average Fee | Income Impact |
|---|---|---|
| 1:50,000 | ₹3000-5000 | ₹100+ lakh |
| 1:20,000 | ₹1500-3000 | ₹60-100 lakh |
| 1:10,000 | ₹1000-2000 | ₹40-60 lakh |
| 1:5,000 | ₹500-1200 | ₹25-40 lakh |
| 1:3,000 | ₹200-500 | ₹15-30 lakh |
| 1:2,000 | ₹100-300 | ₹10-20 lakh |
The relationship is logarithmic: Each doubling of practitioner density causes 30-40% fee compression.
When practitioner-to-population ratio exceeds 1:5,000, commoditization accelerates. When it exceeds 1:3,000, commoditization is entrenched.
How Supply Projections Predict Future Commoditization
Medical education data shows where supply is increasing fastest:
High-supply-increase specialties (>30% increase over 5 years):
- Psychiatry: +40% (government NMHP push)
- Dermatology: +35% (popular with students)
- Pathology: +30% (less competitive specialty, more seats)
- General practice: +20% (ongoing increase)
Moderate-supply-increase specialties (15-30%):
- Pediatrics: +18%
- Orthopedics: +22%
- Anesthesia: +20%
- General surgery: +15%
Low-supply-increase specialties (<15%):
- Cardiology: +12% (competitive specialty, limited seats)
- Neurosurgery: +8% (limited by training centers)
- Interventional radiology: +10%
- Transplant surgery: +3% (ultra-limited seats)
Specialties with >30% supply increase will be commoditizing within 10 years. Psychiatry and dermatology are highest risk.
The Mechanism: Why Supply Increase Leads to Commoditization
When practitioners increase, patients have choices:
- 2010: Only one dermatologist in the city. Patients wait 3 months, pay whatever fee. Dermatologist charges ₹1500.
- 2025: 6 dermatologists in same city. Patients choose based on fee and location. Dermatologist must charge ₹700 to stay competitive.
When patients have choices, quality becomes invisible:
- You're an excellent dermatologist (95% patient satisfaction)
- Competing dermatologist is average (70% patient satisfaction)
- Both charge ₹700 (market rate now)
- Patient chooses based on proximity, availability, not quality
- Your quality advantage is invisible in the transaction
When volume increases, margins compress:
- You used to see 20 patients/day at ₹1500 = ₹30,000 revenue/day
- You now see 40 patients/day at ₹700 = ₹28,000 revenue/day
- You're working 2x harder for 7% less revenue
- Your income per hour drops 50%
Ultimately, commoditized specialty practitioners compete on:
- Price (lowest fee wins)
- Convenience (best location, easiest access wins)
- Insurance acceptance (accepting more insurance plans wins)
- Patient volume (high volume, short appointments wins)
Not on:
- Clinical expertise
- Diagnostic accuracy
- Patient outcomes
- Bedside manner
These are irrelevant in commoditized markets where patient cannot assess quality before choosing.
Strategic Implications: Which Specialties to Pursue
High-risk specialties (avoid if you're early in career):
- Dermatology (commoditizing in 5-10 years)
- Psychiatry (commoditizing in 10-15 years)
- ENT (moderate commoditization in 10-15 years)
- General medicine (already commoditized, avoid unless building government career)
Moderate-risk specialties (pursue with caution + specialization):
- General orthopedics (moderate commoditization in 10-15 years; sub-specialize in arthroscopy, joint replacement, or spine)
- General surgery (commoditization beginning; sub-specialize in minimally invasive, oncology, trauma)
- Pediatrics (slow commoditization; sub-specialize in neonatology, pediatric cardiology, developmental disorders)
Low-risk specialties (pursue if interested, scarcity protects):
- Interventional cardiology
- Minimal-access/robot surgery
- Nephrology interventional
- Pain management interventional
- Pediatric specialties (pediatric cardiology, pediatric neurology, pediatric oncology)
- Reproductive medicine (IVF, ART)
- Neuro-oncology
- Transplant surgery
Ultra-low-risk/emerging specialties (pursue if intellectually aligned):
- Robotic surgery
- Stem cell medicine
- Interventional neuro
- Minimal-access tumor surgery
- Gene therapy (future)
- Precision medicine (future)
The Timing Question: When Should You Decide?
If you're in medical school (choosing specialty):
- Avoid high-risk commoditizing specialties (dermatology, psychiatry, general medicine)
- Choose lower-risk specialties where scarcity protects income
- Consider that by the time you finish training (5-7 years), supply will have increased further
If you're already in a commoditizing specialty:
- Sub-specialize urgently (you have 5-10 year window)
- Build reputation now before supply reaches critical density
- Consider diversification (education, research, administration, consulting alongside clinical practice)
If you're in a non-commoditizing specialty:
- You're in strong position; scarcity is structural
- But don't become complacent; commoditization can accelerate if government pushes supply expansion
The Structural Reality: Commoditization Is Inevitable for Most Specialties
Over 20-30 years, most specialties will commoditize as:
- 1Medical seats increase (government expansion plans)
- 2Training programs proliferate (private colleges opening new programs)
- 3Supply becomes abundant
- 4Competition on price begins
- 5Specialization within specialty becomes necessary
The only protection against commoditization is:
- Continuous specialization (become expert in sub-niche)
- Procedural focus (procedure-based work has higher scarcity value than diagnosis-based)
- First-mover advantage (enter specialty early, build reputation before saturation)
- Institutional affiliation (government positions, academic teaching preserve value longer)
For a career spanning 30-40 years, assume commoditization of your current specialty will happen. Plan for it.
FAQ
Q: If dermatology is commoditizing, should I switch specialties now?
A: Depends on your training stage. If you've completed dermatology training and have 25+ years career ahead, yes, consider sub-specialization (dermatologic surgery, cosmetic dermatology, pediatric dermatology) or diversification. If you're in dermatology residency now, sub-specialize within dermatology rather than switching.
Q: Is psychiatry still worth pursuing given commoditization?
A: Yes, if you sub-specialize (child psychiatry, forensic psychiatry, de-addiction medicine, psychopharmacology) or focus on complex cases (treatment-resistant depression, bipolar disorder management). General psychiatry will commoditize further, but specialized psychiatry will maintain value.
Q: How do I know if my specialty is commoditizing in my state?
A: Check: (1) Practitioner-to-population ratio in your state (higher = more commoditized), (2) Average consultation fees in your specialty (declining = commoditizing), (3) Number of practitioners entering your specialty annually (increasing = supply pressure). Contact your state specialty association for data.
Q: Can I prevent commoditization by being excellent clinically?
A: No. Commoditization is supply-demand dynamics, not quality dynamics. You can be the best dermatologist in city, but if there are 6 other dermatologists at lower fees, patients will choose based on price. Quality is invisible in commoditized markets where patient cannot assess it pre-purchase.
Q: Which specialties are safest from commoditization?
A: Procedure-based specialties where scarcity of trained practitioners persists: interventional cardiology, minimal-access surgery, robotic surgery, interventional radiology, neuro-interventional, transplant surgery. These maintain value because training is limited and procedures are high-revenue.
Q: Should I move to smaller town if my specialty is commoditizing in metros?
A: Yes, partially. Commoditization is slower in smaller towns (lower practitioner density). But smaller towns also have lower absolute income. Moving to tier 2-3 city might slow commoditization impact, but income is still 20-30% lower overall. Trade-off is real.
Q: Is commoditization reversible if supply decreases?
A: Yes, theoretically. If practitioners leave specialty (early retirement, migration), supply decreases, commoditization reverses partially. But this is rare. More common: Specialists within specialty get narrower (remaining practitioners specialize, creating two-tier market: super-specialists at high fees, general specialists at low fees).
futurise. builds premium healthcare brands in 48 hours. Learn more at futurise.studio